ground breaking research, page-46

Something like this article but substitute Angiochem with OBJ and I might need to see my local GP for a pacemaker :)

http://www.fiercedrugdelivery.com/story/gsk-angiochem-dream-brain-delivery-enzyme-disorder-drugs/2012-02-27

Plenty on the go for GSK:

http://www.dddmag.com/news/2009/12/intercell-and-gsk-develop-needle-free-patch-based-vaccines

http://www.dddmag.com/news/2012/03/gsk-daiichi-sankyo-form-vaccine-alliance-japan


The above articles do not involve OBJ but we know that drug delivery is an exciting phase of development and at 2 cents, I am long on this stock as with Glyn recent commentary for 2012 = no brainer.